Within four hours, the system went live. Ananya uploaded the “Drug Alert” onto the IPC’s website, flagging the specific batch number. This wasn't a suggestion. Under the Drugs and Cosmetics Act, this alert forced every state drug controller from Kerala to Kashmir to seize that batch from every pharmacy shelf.
Back in her office the next morning, a new email arrived. A manufacturer in Hyderabad had submitted a new generic antibiotic for monograph inclusion. It was a life-saving drug for drug-resistant tuberculosis. ipksindia
Mr. Mehta’s smile vanished. “We have political connections. This will go away.” Within four hours, the system went live
She was testing a batch of a common antimalarial drug, Artesunate, sent from a manufacturer in Nagpur. The label claimed it contained 500 mg of active ingredient. The machine said 120 mg. The rest was cheap fillers—chalk, starch, and a nasty binder that could cause kidney failure. Under the Drugs and Cosmetics Act, this alert
The liquid turned orange. It should have turned blue.
Rajan adjusted his glasses, looking at the data. He didn't sigh or curse. He simply nodded. “The quality control failure is theirs. The public health failure is ours to prevent. Issue the alert.”
The fluorescent lights of the IPC Reference Lab in Ghaziabad hummed a low, steady note. Dr. Ananya Sharma stared at the High-Performance Liquid Chromatography (HPLC) readout, and her blood ran cold.